US-Russia nuclear arms treaty expires as Trump looks to include China

The New START strategic arms treaty between the U.S. and Russia formally expired after no U.S. response to a one‑year extension offer from Moscow, removing the last legal limits on deployed strategic nuclear warheads and delivery systems; both U.S. and Russian arsenals remain above 4,000 while China’s arsenal is around 600 and projected to exceed 1,000 by 2030. The Trump administration has signaled it wants China included in any successor arrangement, which Beijing rejects, leaving an interim period of heightened strategic uncertainty. Immediate market disruption is unlikely, but the lapse raises medium‑term geopolitical risk that could influence defense sector demand, securitized asset pricing in risk‑off environments, and long‑term intelligence and arms‑control planning.

Analysis

Market structure: The expiration of New START increases political risk premium and is a structural positive for prime U.S. defense contractors (Lockheed LMT, Northrop NOC, Raytheon RTX, General Dynamics GD) and nuclear component suppliers (BWXT). Expect 3–6% incremental government procurement upside to prime contractors over 3–5 years if appropriations follow rhetoric, with downstream pricing power for specialized subsystems (radar, missiles, nuclear-packaging). Near-term winners also include safe-haven assets (Gold GLD, U.S. Treasuries TLT) and the USD; downside pressure on travel/exposed cyclicals and EM FX is likely in the first 0–90 days.

Risk assessment: Tail risk of nuclear escalation is extremely low probability but catastrophic; model a >200bps instantaneous equity risk-off shock in portfolios for contingency planning. Time horizons: days — safe-haven flows and volatility spikes; weeks–months — re-rating of defense capex expectations and earnings revisions; years — sustained modernization programs altering supplier revenue mixes. Hidden dependencies include U.S. Congressional appropriations (must watch FY26 budget cycle), China’s policy response, and intelligence/verification opacity that could erode forward visibility.

Trade implications: Tactical plays: buy GLD and TLT immediately as 0–30 day hedges (size 1–3% each); overweight primes LMT/NOC (initiate 2% position each, add to weakness) and BWXT (1%) for nuclear supply exposure over 12–36 months. Use options: buy 6–12 month call spreads on LMT/NOC (15–25% OTM) to lever upside with capped cost; buy a 2–3 month SPX 5% OTM put spread sized 0.5% notional as tail insurance. Pair trade: long LMT vs short UAL (airlines) 1:1 notional over 3–12 months to express defense vs travel risk-off.

Key Decisions for Investors

• Establish a 2% long position in LMT and a 2% long position in NOC within the next 2–4 weeks; add another 1% each on any 7–10% pullback. Rationale: prime contractors gain 3–6% incremental topline over 3–5 years from modernization programs.
• Initiate a 1% long in BWXT (nuclear components) as a 12–36 month thematic trade; target total position 2% if Congress signals increased nuclear modernization funding in FY26 (watch defense appropriation headlines over next 60–90 days).
• Deploy immediate 1–3% hedges: buy GLD (1.5%) and TLT (1.5%) within 0–14 days to capture short-term risk-off; trim both if 10-year U.S. Treasury yield rises >50bp from current levels or if GLD rallies >10% from entry.
• Purchase 6–12 month call spreads on LMT and NOC (15–25% OTM) sized to 1% notional combined to cap premium while keeping upside; simultaneously buy a 2–3 month SPX 5% OTM put spread sized 0.5% notional as tail insurance against sudden escalation.
• Enter a relative-value pair: long LMT / short UAL (equal notional) sized 1% of portfolio over 3–12 months to express defense upside vs travel/downside; exit or rebalance if airlines trade tighter than -20% or defense names outperform by >25%.